...
dtil-img

Precision BioSciences Inc, Common Stock

DTIL

NAQ

$4.521

+$0.39

(9.44%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$31.68M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
10.325
Volume info-icon
This is the total number of shares traded during the most recent trading day.
72.62K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.69
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.13 L
$19.43 H
$4.521

About Precision BioSciences Inc, Common Stock

Precision BioSciences, Inc., an advanced gene editing company, develops in vivo gene editing therapies for gene edits, including gene elimination, insertion, and excision in the United States. The company offers ARCUS, a genome editing platform to DNA genome insertion, deletion, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; PBGENE-PMM for the treatment of m.3243 associated primary mitochondrial myopathy (PMM) which is expected to submit an IND and/or CTA. In addition, it develops PBGENE-NVS for sickle cell disease/beta thalassemia for insertion; PBGENE-DMD (excision) for duchenne muscular dystrophy; PBGENE-LL2 (insertion), a liver directed target; PBGENE-LL3, a central nervous system directed target; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. The company has license and collaboration agreement with Caribou Biosciences, Inc.; license agreement with TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; development and license agreement with Eli Lilly and Company for the research and development of potential in vivo therapies for genetic disorders; Cellectis S.A.; iECURE, Inc. to develop ARCUS-based gene-insertion therapies; Duke University; and Novartis Pharma AG to discover and develop in vivo gene editing products. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameDTILSectorS&P500
1-Week Return-25.99%-3.39%-3.47%
1-Month Return-43.11%-3.25%-0.29%
3-Month Return-56.98%-11.61%4.5%
6-Month Return-59.11%-5.89%6.91%
1-Year Return-60.89%2.65%23.79%
3-Year Return-98.32%0.56%28.43%
5-Year Return-98.87%34.63%83.64%
10-Year Return-99.21%94.78%185.94%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue22.24M24.29M115.53M25.10M48.73M[{"date":"2019-12-31","value":19.25,"profit":true},{"date":"2020-12-31","value":21.02,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":21.72,"profit":true},{"date":"2023-12-31","value":42.18,"profit":true}]
Cost of Revenue---9.00M8.26M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.68,"profit":true}]
Gross Profit22.24M24.29M115.53M16.09M40.47M[{"date":"2019-12-31","value":19.25,"profit":true},{"date":"2020-12-31","value":21.02,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":13.93,"profit":true},{"date":"2023-12-31","value":35.03,"profit":true}]
Gross Margin100.00%100.00%100.00%64.12%83.06%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":64.12,"profit":true},{"date":"2023-12-31","value":83.06,"profit":true}]
Operating Expenses109.44M134.11M154.93M125.46M92.46M[{"date":"2019-12-31","value":70.64,"profit":true},{"date":"2020-12-31","value":86.56,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":80.98,"profit":true},{"date":"2023-12-31","value":59.68,"profit":true}]
Operating Income(87.20M)(109.83M)(39.40M)(100.37M)(43.74M)[{"date":"2019-12-31","value":-8720400000,"profit":false},{"date":"2020-12-31","value":-10982800000,"profit":false},{"date":"2021-12-31","value":-3940200000,"profit":false},{"date":"2022-12-31","value":-10036600000,"profit":false},{"date":"2023-12-31","value":-4373600000,"profit":false}]
Total Non-Operating Income/Expense(1.59M)1.64M8.88M29.82M6.87M[{"date":"2019-12-31","value":-5.33,"profit":false},{"date":"2020-12-31","value":5.51,"profit":true},{"date":"2021-12-31","value":29.77,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":23.03,"profit":true}]
Pre-Tax Income(92.88M)(109.01M)(30.60M)(111.64M)(42.53M)[{"date":"2019-12-31","value":-9287700000,"profit":false},{"date":"2020-12-31","value":-10900600000,"profit":false},{"date":"2021-12-31","value":-3060200000,"profit":false},{"date":"2022-12-31","value":-11163700000,"profit":false},{"date":"2023-12-31","value":-4252700000,"profit":false}]
Income Taxes(9.58M)10.43M316.00K11.27M27.24M[{"date":"2019-12-31","value":-35.16,"profit":false},{"date":"2020-12-31","value":38.29,"profit":true},{"date":"2021-12-31","value":1.16,"profit":true},{"date":"2022-12-31","value":41.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(83.30M)(119.43M)(30.92M)(122.91M)(69.77M)[{"date":"2019-12-31","value":-8330100000,"profit":false},{"date":"2020-12-31","value":-11943470300,"profit":false},{"date":"2021-12-31","value":-3091800000,"profit":false},{"date":"2022-12-31","value":-12290800000,"profit":false},{"date":"2023-12-31","value":-6976500000,"profit":false}]
Income From Continuous Operations(92.88M)(109.01M)(30.60M)(111.64M)(87.25M)[{"date":"2019-12-31","value":-9287700000,"profit":false},{"date":"2020-12-31","value":-10900600000,"profit":false},{"date":"2021-12-31","value":-3060200000,"profit":false},{"date":"2022-12-31","value":-11163700000,"profit":false},{"date":"2023-12-31","value":-8724800000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(83.30M)(109.01M)(30.92M)(122.91M)(61.32M)[{"date":"2019-12-31","value":-8330100000,"profit":false},{"date":"2020-12-31","value":-10900600000,"profit":false},{"date":"2021-12-31","value":-3091800000,"profit":false},{"date":"2022-12-31","value":-12290800000,"profit":false},{"date":"2023-12-31","value":-6131900000,"profit":false}]
EPS (Diluted)(3.15)(2.09)(0.68)(1.40)(4.46)[{"date":"2019-12-31","value":-315,"profit":false},{"date":"2020-12-31","value":-209,"profit":false},{"date":"2021-12-31","value":-68,"profit":false},{"date":"2022-12-31","value":-140,"profit":false},{"date":"2023-12-31","value":-446,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

DTIL
Cash Ratio 8.45
Current Ratio 9.22

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

DTIL
ROA (LTM) -6.38%
ROE (LTM) 24.44%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

DTIL
Debt Ratio Lower is generally better. Negative is bad. 0.58
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.42

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

DTIL
Trailing PE 10.32
Forward PE 2.11
P/S (TTM) 0.42
P/B 0.49
Price/FCF NM
EV/R 0.18
EV/Ebitda NM

FAQs

What is Precision BioSciences Inc share price today?

Precision BioSciences Inc (DTIL) share price today is $4.521

Can Indians buy Precision BioSciences Inc shares?

Yes, Indians can buy shares of Precision BioSciences Inc (DTIL) on Vested. To buy Precision BioSciences Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DTIL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Precision BioSciences Inc be purchased?

Yes, you can purchase fractional shares of Precision BioSciences Inc (DTIL) via the Vested app. You can start investing in Precision BioSciences Inc (DTIL) with a minimum investment of $1.

How to invest in Precision BioSciences Inc shares from India?

You can invest in shares of Precision BioSciences Inc (DTIL) via Vested in three simple steps:

  • Click on Sign Up or Invest in DTIL stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Precision BioSciences Inc shares
What is Precision BioSciences Inc 52-week high and low stock price?

The 52-week high price of Precision BioSciences Inc (DTIL) is $19.43. The 52-week low price of Precision BioSciences Inc (DTIL) is $4.13.

What is Precision BioSciences Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Precision BioSciences Inc (DTIL) is 10.325

What is Precision BioSciences Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Precision BioSciences Inc (DTIL) is 0.49

What is Precision BioSciences Inc dividend yield?

The dividend yield of Precision BioSciences Inc (DTIL) is 0.00%

What is the Market Cap of Precision BioSciences Inc?

The market capitalization of Precision BioSciences Inc (DTIL) is $31.68M

What is Precision BioSciences Inc’s stock symbol?

The stock symbol (or ticker) of Precision BioSciences Inc is DTIL

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top